Isochromosome 7p, i(7)(p10): A rare AML, myelodysplasia-related entity.

20q deletion 7q deletion Acute myeloid leukemia Chromosome microarray analysis Mutations i(7p)

Journal

Leukemia research reports
ISSN: 2213-0489
Titre abrégé: Leuk Res Rep
Pays: England
ID NLM: 101608906

Informations de publication

Date de publication:
2023
Historique:
received: 21 07 2023
accepted: 25 08 2023
medline: 13 9 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: epublish

Résumé

We describe genomic findings in an AML case with isochromosome 7p, i(7)(p10), in which SNP array analysis uncovered an additional 7.07-Mb 20q deletion not detected by karyotyping. Several AML cases with i(7)(p10) as an isolated cytogenetic finding have been previously reported. Based on consequent loss of 7q, we propose that AML with i(7)(p10) represents a distinct entity belonging in the WHO group -7/7q-, which represents one of the genetic abnormalities defining AML, myelodysplasia-related. Additionally, the focal del(20q) identified here adds support for a specific common region of deletion in 20q in myeloid malignancies, implicating a small number of candidate genes.

Identifiants

pubmed: 37701905
doi: 10.1016/j.lrr.2023.100387
pii: S2213-0489(23)00027-4
pmc: PMC10493252
doi:

Types de publication

Case Reports

Langues

eng

Pagination

100387

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors have no financial or personal relationships with other people or organizations that could inappropriately influence the work reported in this manuscript. The research was performed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Blood. 2010 Sep 23;116(12):2122-6
pubmed: 20538800
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Prostate Cancer Prostatic Dis. 2021 Mar;24(1):233-243
pubmed: 32873916
Oncogene. 2000 Aug 10;19(34):3902-13
pubmed: 10952764
Elife. 2013 Jul 16;2:e00825
pubmed: 23878725
Blood. 2017 Aug 10;130(6):722-731
pubmed: 28588020
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Genes Chromosomes Cancer. 2010 Apr;49(4):390-9
pubmed: 20095039
Front Oncol. 2021 Jul 26;11:704471
pubmed: 34381727

Auteurs

Reza Nejati (R)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.

Ryan Neumann-Domer (R)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
Clinical Cytogenomics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Zemin Liu (Z)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
Clinical Cytogenomics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Lori Koslosky (L)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
Clinical Cytogenomics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Erin Neumann-Domer (E)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
Clinical Cytogenomics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Jianming Pei (J)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
Molecular Diagnostics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Y Lynn Wang (YL)

Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
Molecular Diagnostics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Joseph R Testa (JR)

Clinical Cytogenomics Lab, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Classifications MeSH